DBV Technologies (CHIX:DBVP) Total Liabilities: €50.60 Mil (As of Mar. 2026)


CHIX:DBVP DBV Technologies SA CHIX:DBVP
31 GF Score
Price €2.91
! 1 Warning Sign
View Full Analysis

What is DBV Technologies Total Liabilities?

DBV Technologies CHIX:DBVP 31 Total Liabilities is €50.60 Mil as of Mar. 2026. GuruFocus rates CHIX:DBVP with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

DBV Technologies's Total Liabilities for the quarter that ended in Mar. 2026 was €50.60 Mil.

DBV Technologies's quarterly Total Liabilities increased from Sep. 2025 (€49.11 Mil) to Dec. 2025 (€55.47 Mil) but then declined from Dec. 2025 (€55.47 Mil) to Mar. 2026 (€50.60 Mil).

DBV Technologies's annual Total Liabilities declined from Dec. 2023 (€39.25 Mil) to Dec. 2024 (€36.55 Mil) but then increased from Dec. 2024 (€36.55 Mil) to Dec. 2025 (€55.47 Mil).

DBV Technologies Total Liabilities Historical Data

* Premium members only.

The historical data trend for DBV Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DBV Technologies Total Liabilities Chart

DBV Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.99 49.15 39.25 36.55 55.47

DBV Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.11 49.60 49.11 55.47 50.60
CHIX:DBVP
31GF Score
DBV Technologies SA CHIX:DBVP
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DBV Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

DBV Technologies's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=49.553+(4.619+1.294
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=55.47

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=199.595-144.13
=55.47

DBV Technologies's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=44.807+(4.411+1.384
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=50.60

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=230.436-179.833
=50.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €50.60 Mil mean?
DBV Technologies (CHIX:DBVP) has a Total Liabilities of €50.60 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for DBV Technologies and its competitors.
Is DBV Technologies' Total Liabilities too high?
DBV Technologies' current Total Liabilities is €50.60 Mil. Overall, DBV Technologies has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does DBV Technologies' Total Liabilities compare to VRTX and REGN?
DBV Technologies' Total Liabilities of €50.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for DBV Technologies and its competitors. DBV Technologies's current Total Liabilities is €50.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DBV Technologies stock overvalued right now?
DBV Technologies (CHIX:DBVP) has a current Total Liabilities of €50.60 Mil. The current Total Liabilities is €50.60 Mil. DBV Technologies' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For DBV Technologies (CHIX:DBVP), the current Total Liabilities is €50.60 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DBV Technologies Business Description

Address 107 Avenue de la Republique, Batiment IRO, Chatillon, Paris, FRA, 92320
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
31GF Score

Get the complete analysis for CHIX:DBVP

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.91
Price